Skip to main content
. 2020 Nov 21;109(1):233–242. doi: 10.1002/cpt.2088

Table 2.

Summary of data used for model training and model evaluation

Parameter Units Model training population Model evaluation population
Patients n 350 323
Vancomycin levels n 1,549 1,290
Doses n 6,154 5,249
Levels per patient median, (range) n 2 (1–38) 2 (1–49)
Peak samples n (%) 16 (1.0%) 15 (1.2%)
Level value, median (range) mg/L 11 (1–56) 11 (0–60)
Percent male % 60.6 57.0
Age, median (range) years 3.5 (0.2–20.5) 3.85 (0.2–20.2)
Weight, median (range) kg 12.25 (2.1–110.6) 15.1 (2.7–160.7)
SCR at treatment start, median (range) years 0.3 (0.1–9.4) 0.3 (0.1–9)

SCR, creatinine.